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High prevalence of abdominal aortic aneurysms in
brothers and sisters of patients despite a low
prevalence in the population
Anneli Linné, MD,a,b David Lindström, MD, PhD,c,d and Rebecka Hultgren, MD, PhD,c,d Stockholm, Sweden
Objective: Population-based screening for abdominal aortic aneurysms (AAAs) in elderly men is organized in many
regions and countries in the Western world, and the prevalence of disease is reported to decline. Whether the prevalence
among those with a family history also is declining is unknown. The primary purpose of this study was to assess the
prevalence of AAAs among siblings of persons with AAAs and to investigate the proportion of siblings already diagnosed
by opportunistic screening.
Methods: Patients treated for AAAs from January 2008 through December 2010 (n  412) in Stockholm, Sweden, were
screened for siblings. Seven hundred seventy-nine siblings were identified. All siblings <80 years residing in Stockholm
County were considered eligible and were invited to participate in the study (n  174). Deceased siblings were not
included in the study, regardless of the cause of death. One hundred fifty siblings were enrolled in the study after
informed consent was provided. One hundred thirty-four siblings were screened for AAAs with ultrasound scan and
maximum aortic, infrarenal, anteroposterior, external (outer-to-outer) aortic diameter was measured. Characteristics of
siblings with and without AAAs were compared.
Results: The mean age of the screened siblings was 66.4 years (standard deviation, 7.1). Of the siblings, 11% were found
to have an AAA, 17% (n  11) of the brothers, and 6% (n  5) of the sisters. Only 11% of the siblings were screened for
AAAs before the study. One of 16 siblings with AAAs was <65 years. Ever smoking was evident in 81% of the AAA
siblings compared to 59% in the non-AAA siblings. Factors associated with increased risk of AAAs in the multivariate
regression analysis were: male sex (odds ratio, 3.4; 95% confidence interval, 1.1-10.8; P  .04) and age >65 (odds ratio,
10.8; 95% confidence interval, 1.3-86.4; P  .03). Ever smoking was not statistically significant as a risk.
Conclusions: A strikingly high prevalence of AAAs in siblings was found as compared to the reported declining aneurysm
prevalence in elderly men in the Western world. Systematic improvements regarding screening of first-degree relatives is
mandated and selective screening of siblings is an underused tool to prevent death from aneurysm disease, both among
men and women. (J Vasc Surg 2012;56:305-10.)
r
s
o
p
n
c
t
t
7
C
fi
d
w
T
b
t
a
i
t
A
t
T
lScreening programs for detection of abdominal aortic
aneurysms (AAAs) is now frequently implemented in the
Western world,1-3 the rationale being an approximately
40% to 50% reduction of AAA-associated mortality in
men.4-9 Different guidelines regarding which groups to
select for screening have been published by several organi-
zations.5,10-13 The guidelines are fairly consistent regard-
ing the recommendation to perform one-time screening in
elderly, smoking men, but varies widely regarding non-
smokers and persons with a family history of AAAs. In a
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doi:10.1016/j.jvs.2012.01.061ecent review of guidelines, the need for further studies on
ubgroups such as siblings was postulated.14
In Sweden, the population-based screening programs
f 65- to 70-year-old men, now covering 90% of the
opulation, show prevalence rates of 1.7%.15 The prelimi-
ary prevalence rates are lower than anticipated but are
onsistent with recently published data from other coun-
ries.2,7,15,16 Regarding prevalence in women, a publica-
ion from the United States reports a prevalence of 0.7% in
0-year-old women17 as compared to the 1.3% in the
hichester report for women.18 The increased risk for
rst-degree relatives (FDRs) of patients with AAAs to also
evelop AAAs has been published in several reports19-28
ith resulting prevalence rates ranging from 3% to 19%.
he wide range is likely due to differences in study design
ut also regional differences in prevalence (Table I). Al-
hough the increased risk for an AAA in FDRs is well known
mong vascular surgeons, it is uncertain how the actual
mplementation of this knowledge on sisters and brothers
o patients with AAAs is undertaken. The prevalence of an
AA seems to be declining, but if the prevalence among
hose with a family history also is declining is not known.
he primary purpose of this study was to assess the preva-
ence of AAAs among siblings of persons with AAAs and to
ompare characteristics of siblings with and without AAAs.
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siblings already diagnosed by opportunistic screening.
METHODS
Study population. All vascular patients in Stockholm
County (2.1 million inhabitants) are treated at the Depart-
ment of Vascular Surgery at the Karolinska University
Hospital or Södersjukhuset Hospital. All patients treated
for AAAs in Stockholm from January 2008 through De-
cember 2010 were invited to join the study. To avoid
diagnosing siblings not eligible for treatment, siblings80
years were not included. There was no lower age limit.
Patients with AAAs were contacted through a letter or at
their hospital visit; 779 siblings were identified, 449 were
still alive. Permission to contact siblings was obtained from
the proband patients. All siblings80 years living in Stock-
holm county were considered eligible and were invited to
participate in the study (n 174; Fig 1). Forty-two siblings
were not invited due to proband inability to find/give
contact information, and 14% (n  24) declined participa-
tion (Fig 1). Deceased siblings were not included or ana-
lyzed regardless of their cause of death.
The study was approved by the regional Ethics Com-
mittee in Stockholm.
Interview. A structured telephone interview by an
experienced study nurse was performed after informed
consent was provided. The protocol covered comorbid
conditions, ongoing medication, smoking habits, weight,
height (body mass index), and previous surgery. The inter-
view was performed before the people were invited to the
ultrasound scan examination.
Smoking was defined as “ever smoker” or “never smok-
er”; ever smoker includes ongoing smokers and previous
smokers. Hypertension, ischemic heart disease, congestive
heart failure, diabetes mellitus, and chronic obstructive
pulmonary disease were defined by the need of chronic or
intermittent pharmacologic treatment. All medical condi-
tions were self-reported at the structured interview.
Ultrasound scan examination. Siblings were screened
for AAAs with ultrasound scans by one experienced vascular
Table I. Selection of previous studies investigating freque
Author (year of publication) No. of proband AAA
Larsson et al19 (2010) 3183
Badger et al20 (2007) 132
Ogata et al21 (2005) 375
Frydman et al33 (2003)
Rossaak et al22 (2001) 248
Salo et al23 (1999) 238
Lederle et al24 (1997) 3
van der Lugt et al27 (1992) 32
Webster et al28 (1991) 49
Bengtsson et al32 (1989) 84
Darling et al26 (1989) 542
AAA, Abdominal aortic aneurysm; FDR, first-degree relative.
aAneurysmal and ectatic 2.5 cm.surgeon, using a GE Logiq E ultrasound (GE Healthcare, maukesha, Wisc), curved array 4- to 7-MHz probe. The
nterobserver and intraobserver variability was tested by an
xternal examiner with blinded repeated measurements of
he aorta in 10 patients. The variability was1mm (intrao-
server) and 2 mm (interobserver). All ultrasound scans
ere performed by one examiner. Maximum aortic, infra-
enal, anteroposterior, external (outer-to-outer) diameter
as measured in transverse and sagittal positions5,29 (Fig
). According to a clinical practice in Stockholm, con-
luded from a Swedish population study,30 30 mm in
ig 1. Study selection flow chart. AAA, Abdominal aortic
neurysm.
f AAAs in siblings/FDR
s Brothers % Sisters % Total %
8
5.9 1.8 3.9
29 11 19
43a 16a 30a
19
10.8 0 5
9
28.6 5.8
25 6.9
29 6
19ncy o
caseen and27mm in women was considered to be an AAA.
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Volume 56, Number 2 Linné et al 307Statistics. Univariable logistic regression models were
estimated for an aneurysm as outcome where the variables
with a P value .10 were included in a multivariable model.
The variable agewas dichotomized in themainmodel butwas
also included as a continuous variable and modeled using a
restricted cubic spline with 4 degrees of freedom to visualize
the functional form. TheHosmer-Lemeshow goodness-of-fit
was performed for the multivariable model and outliers were
checked by means of the dfbetas, whereas the variance infla-
tion factor was used to detect possiblemulticollinearity. Inter-
actions were tested within the multivariable model and inter-
actions were also used to visually display the combination of
characteristics in a Forest plot. Data were analyzed in SPSS
18.0 (IBM Corporation, Armonk, NY). P values .05 were
considered significant.
RESULTS
One hundred fifty Caucasian siblings (age range, 45 to
79 years) were enrolled in the study, 44% (n  66) were
brothers of the proband patients, and 56% (n  84) were
sisters. A total of 11% of the 150 included siblings had
recently been screened for AAAs. The remaining 134 were
examined with ultrasound scans.
Baseline characteristics of all siblings are shown in
Table II. Mean age was 66.3 years (standard deviation, 7.1)
and 59% were current or previous smokers (ever-smokers).
Among all siblings, 11% (n  16) were found to have an
AAA, 17% (n  11) of brothers and 6% (n  5) of sisters.
Six of the siblings had a previously diagnosed AAA, of
which five had been treated surgically. Mean age in the
AAA-diagnosed siblings was 71.6 vs 65.7 in the non-AAA
group. None of themale siblings with AAAs were in the age
group 55 years, one was 56 to 65 years, eight were 66 to
75 years, and two were 76 to 80 years. Of the female
siblings with AAAs, none were in the groups 55 years or
56 to 65 years, five were in the group 66 to 75 years, and
one was 76 to 80 (Table II). Among siblings with AAAs,
Fig 2. Ultrasound scan was performed measuring the maximum
transverse, anteroposterior, and infrarenal diameter, outer-to-
outer measure used.81% were ever-smokers compared to 59% of the non-AAA liblings. Of the 16 AAAs, six were50 mm, one was 40 to
9mm, six were 30 to 39mm, and three were 27 to 29mm
women). In the univariate regression analysis (Table III),
ale vs female gender was associated with an increased risk
o have an AAA, as was age65 years. These three variables
ere introduced in a multivariable model. Factors associated
ith an increased risk of AAAs in multivariate analysis were
ale gender and age65 years. Smoking did not contribute
ith a statistically significant increased risk (Table IV).
ISCUSSION
The prevalence in our sibling cohort was strikingly high
oth in sisters and brothers. The recently reported preva-
able II. Demographics of sibling cohort
AAA % (n)
Non-AAA
% (n)
ean age (SD) 71.6 (4.8) 65.7 (7.1)
ge groups
55 (n  11) 0 (0) 8 (11)
56-65 (n  56) 6 (1) 41 (55)
66-75 (n  71) 81 (13) 43 (58)
76-80 (n  12) 13 (2) 8 (10)
isk factors/medications
Ever-smokers 81 (13) 59 (79)
Hypertension 62 (10) 51 (69)
Heart disease (IHD/CHF) 25 (4) 21 (28)
COPD/asthma 0 (0) 8 (11)
Diabetes 6 (1) 11 (15)
Statins 38 (6) 16 (37)
ASA 62 (10) 22 (29)
AA, Abdominal aortic aneurysm; ASA, ongoing medication with acetyl-
alicylic acid; CHF, congestive heart failure; COPD, chronic obstructive
ulmonary disease; IHD, ischemic heart disease; SD, standard deviation;
tatins, ongoing medication with statins.
able III. Univariate analysis of risk factors for AAAs in
iblings
OR 95% CI P value
ale gender 3.2 1.04-9.60 .04a
ge 65 9.5 1.22-74.17 .03a
ver-smoker 3.0 0.82-11.09 .096
ypertension 1.55 0.53-4.49 .42
HD/CHF 1.25 0.37-4.18 .72
iabetes 1.92 0.24-15.61 .54
AA, Abdominal aortic aneurysm; CHF, congestive heart failure; CI,
onfidence interval; IHD, ischemic heart disease; OR, odds ratio.
P  .05.
able IV. Multivariate regression analysis
isk factors for AAAs in siblings OR 95% CI P value
ge 65 10.8 1.3-86.4 .03
ale gender 3.4 1.1-10.8 .04
ver-smoker 3.4 0.9-12.9 .08
AA, Abdominal aortic aneurysm; CI, confidence interval; OR, odds ratio.ence in 65-year-old men from Sweden and the United
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August 2012308 Linné et alKingdom was 1.7%.12,15 The unexpected high prevalence
of 6% in sisters in this study, in the light of the reported
prevalence data of 0.7% on 70-year-old women in the
United States,17 should lead us to discuss the current
screening recommendations for siblings.
Abdominal aortic aneurysm screening varies around the
world. In Sweden, there are now regional screening pro-
grams covering 90% of the male 65-year-old population,
but there is a lack of national guidelines regarding screening
of FDRs. There is a widespread knowledge regarding the
hereditary aspect of the AAA disease, but, in this aspect, our
own system has failed because only 11% of the siblings in
this study had actually been subject to ultrasound scan
examination. In the United States, 65-year-old men who
have smoked 100 cigarettes and men/women who have
FDRs with AAAs are invited to one free screening within 12
months of entering the Medicare Program. In the United
Kingdom, the nationwide screening program for 65-year-
old men started in 2009 and is planned for national cover-
age in 2013. In The Netherlands, there is a developed
system to screen siblings, but there is no population-based
screening.14
Current screening guidelines lack consensus re-
garding siblings. Guidelines regarding selection of
groups for screening have been published in 2005 to 2010
by several organizations such as the US Preventive Services
Task Force (USPSTF),11 the American College of Cardiol-
ogy/American Heart Association (ACC/AHA),10 the Na-
tional Screening Committee (NSC United Kingdom),12
the Society of Vascular Surgery (SVS),5 and the Canadian
Society of Vascular Surgery (CSVS).13 The guidelines are
fairly consistent regarding the recommendation to perform
one-time screening in ever-smoking men 65 years old, but
they vary regarding nonsmokers and women with or with-
out a family history of AAA. Regarding women, the USP-
STF and ACA/AHA recommend against screening in
women regardless of family history and smoking, whereas
the SVS and CSVS recommend screening in women 65
with one (SVS) or more (CSVS) risk factors (ie, smoking,
FDR). In the recent guideline review by Ferket et al,14
further analysis regarding cost-effectiveness for screening
these subgroups is necessary. The need for further studies
regarding subgroups such as siblings is also concluded in
many of the publications cited in these guidelines. The
recommendation by the USPSTF against screening of
women is based on the lack of benefit in long-term mortal-
ity and rupture rate after 10 years in the Chichester study18
in which the frequency of aneurysms among women was
1.3%. There are several published studies showing increased
risk for AAAs in siblings and FDRs (Table I). These reports
show an increased risk for FDRs in general (odds ratio,
1.9)19 with a higher risk for monozygotic twins and also an
increased risk regardless of gender.21,27,31-33 The lower risk
for sisters compared to brothers in our study should not be
interpreted as if sisters have a low risk in general. The overall
risk for siblings is high compared to the general population,
regardless of gender. The high number of affected sisters in Mur cohort should be compared to the low prevalence in the
emale population.
There are never-smokers among abdominal aortic
neurysm-diagnosed siblings. The decline in prevalence
n the general population has been suggested to be a result
f decreased smoking.15,16 In our cohort of siblings, the
ate of ever-smokers was high (81%) and the number of
urrent smokers 25%. This is supported by smoking statis-
ics from the general population in Sweden (Folkhälsoin-
titutet) where the number of daily smokers in 2008 to
009 among the 65- to 74-year-old population was 13.5%
n men and 16.6% in women.34 In a recently published
tudy from Northern Ireland,3 the frequency of current
mokers was still 31% in 2002 and a screening study shows
n AAA prevalence of 5.5%. This AAA frequency is high
ompared to other recent data and the high smoking
revalence further supports the theory regarding smoking.
he fact that 18% of the AAA-siblings in this cohort are
ever-smokers is notable.
Safe age to screen siblings. Only one sibling 65
ears (male, 61 years, previous smoker) was found with an
neurysm, even though 53 of the 150 siblings in our cohort
ere65 years. The youngest sisters diagnosed with AAAs
ere 69 years (n  2). The recommended age for male
ibling screening varies from 50 to 60 years.5,10,14,35 There
ere no cases of AAAs in sisters65 years old in this study,
hich would support the SVS position statements5 to
creen female siblings over the age of 65.
Limitation and strengths. Although our study was
imited by small numbers, it reflects siblings to all diag-
osed patients with AAAs in our region during the study
eriod. It is reasonable to believe that our exclusion of
iblings 80 has resulted in an underestimation of the
revalence, but it has resulted in identification of patients
ith aneurysms who can be considered clinically relevant.
he risk of an overestimation of the prevalence is low. The
umbers of siblings with AAAs would presumably be
igher if deceased siblings and siblings older than 80 years
ould have been included. There is no reason to believe
hat siblings who have moved to another county would
epresent a group with a different risk of AAAs; therefore,
his should not bias the results.
ONCLUSIONS
Our study shows a prevailing high prevalence of AAAs
mong siblings despite the reported low aneurysm preva-
ence in men in the Western world. The majority of siblings
f patients with AAAs have not been screened, although the
nowledge of the hereditary patterns is well known. Al-
hough AAA screening of the total male population is
ecoming more common, selective screening of siblings is
n underused tool to prevent death from aneurysm disease,
oth among men and women. Systematic improvements
egarding FDR screening, especially female FDRs, is man-
ated. Our data support screening of all siblings.
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